Login to Your Account

Immunex Sells Leukine For $380M In Preparation For Amgen Merger

By Kim Coghill

Monday, May 6, 2002
In another step toward completing the merger of Immunex Corp. and Amgen Inc., the former on Friday said it has found a buyer for its cancer drug, Leukine. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription